The wolf in sheep's clothing: Platelet-derived "pseudo self" impairs cancer cell "missing self" recognition by NK cells

OncoImmunology

Volumn 1, Issue 4, 2012, Pages 557-559

  Placke, Theresa ^a   Kopp, Hans Georg ^a   Salih, Helmut Rainer ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Cancer; Metastasis; MHC class i; NK cells; Platelets; Thrombocytes; Tumor immunosurveillance

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; NATURAL KILLER CELL RECEPTOR NKG2D; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CANCER CELL; CANCER GROWTH; CANCER IMMUNOTHERAPY; CANCER INHIBITION; CELL INTERACTION; CONFOCAL MICROSCOPY; HUMAN; IMMUNOELECTRON MICROSCOPY; IMMUNOMODULATION; IMMUNOPHENOTYPING; IMMUNOREACTIVITY; IMMUNOSURVEILLANCE; LYMPHOCYTE DEPLETION; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTE FUNCTION; TUMOR ESCAPE;

EID: 84867367707     PISSN: 21624011     EISSN: 2162402X     Source Type: Journal    
DOI: 10.4161/onci.19367     Document Type: Article

References (10)

1. Vivier E, Raulet DH, Moretta A, Caligiuri MA, Zitvogel L, Lanier LL, et al. Innate or adaptive immunity? The example of natural killer cells. Science 2011; 331:44-9; PMID:21212348; http://dx.doi.org/10.1126/science.1198687
2. Gay LJ, Felding-Habermann B. Contribution of platelets to tumour metastasis. Nat Rev Cancer 2011; 11:123-34; PMID:21258396; http://dx.doi.org/10.1038/nrc3004
3. Semple JW, Italiano JE, Jr., Freedman J. Platelets and the immune continuum. Nat Rev Immunol 2011; 11:264-74; PMID:21436837; http://dx.doi.org/10.1038/nri2956
4. Nieswandt B, Hafner M, Echtenacher B, Männel DN. Lysis of tumor cells by natural killer cells in mice is impeded by platelets. Cancer Res 1999; 59:1295-300; PMID:10096562
5. Placke T, Oergel M, Schaller M, Jung G, Rammensee HG, Kopp HG, et al. Platelet-derived MHC Class I confers a pseudo- normal phenotype to cancer cells that subverts the anti-tumor reactivity of natural killer immune cells. Cancer Res 2011; 72:440-8; PMID: 22127925; http://dx.doi.org/10.1158/0008-5472.CAN-11-1872
6. Zitvogel L, Tesniere A, Kroemer G. Cancer despite immunosurveillance: immunoselection and immunosubversion. Nat Rev Immunol 2006; 6:715-27; PMID:16977338; http://dx.doi.org/10.1038/nri1936
7. Placke T, Kopp HG, Salih HR. Modulation of natural killer cell anti-tumor reactivity by platelets. J Innate Immun 2011; 3:374-82; PMID:21411974; http://dx.doi.org/10.1159/000323936
8. Kopp HG, Placke T, Salih HR. Platelet-derived transforming growth factor-beta down-regulates NKG2D thereby inhibiting natural killer cell antitumor reactivity. Cancer Res 2009; 69:7775-83; PMID:19738039; http://dx.doi.org/10.1158/0008-5472.CAN-09-2123
9. Karpatkin S, Pearlstein E, Ambrogio C, Coller BS. Role of adhesive proteins in platelet tumor interaction in vitro and metastasis formation in vivo. J Clin Invest 1988; 81:1012-9; PMID:3280598; http://dx.doi.org/10.1172/JCI113411
10. Ljunggren HG, Malmberg KJ. Prospects for the use of NK cells in immunotherapy of human cancer. Nat Rev Immunol 2007; 7:329-39; PMID:17438573; http://dx.doi.org/10.1038/nri2073